Two Scandinavian countries have declared that their health authorities will place at least a temporary pause on using the Moderna mRNA-based COVID-19 vaccine due to safety concerns based on reports of side effects such as myocarditis. The Swedish health agency’s chief epidemiologist, Anders Tegnell, went on the record stating, “The connection is especially clear when it comes to Moderna’s Spikevax, especially after the second dose.” While the health authorities here acknowledge the incidences are rare, there is enough concern to issue the halt, at least temporarily for young people.
The agency making the call is known as Folkhalsomyndigheten or The Public Health Agency of Sweden. In a recent statement, the Public Health Agency of Sweden reported that all mRNA-1273 vaccinations would be paused for people born in 1991 and after as data indicates the higher risk of inflammation of the heart or heart lining—challenges known as myocarditis and pericarditis among those that fall in the age cohort—that is age 30 and under.
Multiple press outlets such as Reuters shared that Tegnell declared, “Sweden would follow the situation closely and act quickly to ensure tha...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).